Windlas Biotech Announces ₹47 Crore Share Buyback at ₹1,000 per Share

Windlas Biotech Limited (BSE: 543329, NSE: WINDLAS), a leading pharmaceutical formulation manufacturer, has announced that its Board of Directors has approved a proposal to buy back up to 4,70,000 fully paid-up equity shares. The buyback will be conducted via the "Tender Offer" route at a price of ₹1,000 per share.

Key Highlights of the Buyback

The board has authorized the repurchase of shares representing approximately 2.23% of the total paid-up equity capital of the company.

Buyback Price: ₹1,000 per equity share.

Total Buyback Size: Up to ₹47 Crore.

Methodology: Tender Offer on a proportionate basis.

Eligibility: All eligible shareholders as of the Record Date.

Promoter Participation: The Promoters and members of the Promoter Group have expressed their intention not to participate in this buyback.

Reservation for Small Shareholders: In accordance with SEBI regulations, 15% of the total buyback shares (or the entitlement of small shareholders, whichever is higher) will be reserved for small shareholders.

Important Dates and Compliance

The company has established a quick timeline for the identification of eligible shareholders:

Record Date: Friday, April 24, 2026.

Manager to the Buyback: Fintellectual Corporate Advisors Private Limited.

Compliance Officer: Mr. Ananta Narayan Panda, Company Secretary.

As of March 31, 2026, the company's pre-buyback shareholding reflects that the Promoter Group holds 61.90%, while public shareholders (including resident individuals, mutual funds, and others) hold the remaining 38.10%. The final post-buyback shareholding pattern will be determined after the completion of the offer.


The buyback size represents 9.80% of the aggregate of the total paid-up equity share capital and free reserves based on the latest audited financial statements. By opting for a tender offer at a significant price of ₹1,000 per share, the company aims to return surplus cash to its shareholders while potentially improving financial ratios such as earnings per share (EPS) and return on equity (ROE).

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 865.40 as compared to the previous close of Rs. 871.75. The total number of shares traded during the day was 14527 in over 1321 trades.

The stock hit an intraday high of Rs. 888.30 and intraday low of 849.00. The net turnover during the day was Rs. 12637608.00.

Source : Equity Bulls

Keywords

WindlasBiotech CDMO Buyback TenderOffer